Could a poop pill save lives? new trial targets superbug lung infections in ICU patients
NCT ID NCT06970262
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This study tests whether fecal microbiota transplantation (FMT) — transferring healthy donor stool into the gut — can lower the risk of death in ventilated ICU patients with multidrug-resistant lung infections. The idea is that restoring gut bacteria may help fight lung infections through the gut-lung connection. About 60 adults will receive either standard care or standard care plus FMT via a feeding tube, and researchers will track survival at 28 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOOD INTOLERANCE SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny study tracks bacteria as teeth vanish and implants arrive
- Could your workout change the germs in your mouth?
- C-Section babies may get a microbial boost from mom
- Could donor milk give late preterm babies a healthier start than formula?
- Donor milk experiment halted: did matching help tiny babies?
- Magnetic pulses may tame implant gum infection